The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A.

Blood · 2023 · PMC10651782 · PMID 36108308

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The overall drug effect did not reach statistical significance, but rondaptivon pegol inhibited ristocetin-induced aggregation by 19% on day 35 ( supplemental Figure 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.